BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 24 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,890,312 | -2.7% | 1,582,450 | -0.1% | 26.01% | +102.0% |
| Q2 2023 | $10,168,497 | -10.8% | 1,583,878 | +3.5% | 12.88% | +25.2% |
| Q1 2023 | $11,398,500 | +170357.6% | 1,530,000 | 0.0% | 10.29% | +27.9% |
| Q4 2022 | $6,687 | -99.9% | 1,530,000 | +27.7% | 8.04% | +9.4% |
| Q3 2022 | $6,733,000 | +89.7% | 1,198,000 | +94.8% | 7.35% | +85.5% |
| Q2 2022 | $3,549,000 | -53.3% | 615,000 | -18.0% | 3.96% | -51.4% |
| Q1 2022 | $7,605,000 | +17.0% | 750,000 | -4.5% | 8.16% | +31.2% |
| Q4 2021 | $6,500,000 | – | 785,000 | – | 6.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynwood Capital Management Inc. | 1,582,450 | $9,890,312 | 26.01% |
| Rosenberg Matthew Hamilton | 12 | $75 | 0.00% |